RMIT Global Business Innovation Conversations

Presented by RMIT, GBIC is a series of research-driven events showcasing the latest technology and innovation predicted to
propel the future of business.

[RMIT Global Business Innovation Conversations @RMITGBIC]

A big thank you for all who attended the launch of two RMIT white papers on the adoption and diffusion of disruptive technologies: the case of 3D Printing in the medical device industry! #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

"Australian patients, Australian manufacturing, Australian jobs and engineers. I could not think of a better place to startup a MedTech company than here." - Mick Shaddock from OMX Solutions. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

"The main reason to adopt 3D printing for oncology cases is to save lives." George Faithfull from Stryker. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

"How do you regulate AI integration with 3D printed medical device manufacturing? It is something we really need to start looking at." - Dr Jasamine Coles-Black of @3dmedLab #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

"There seems to be pockets of excellence and success with 3D printed implants that is driven by Australian surgeon's. But people are secretive about it and nobody shares their solution." -Dominic Parsonson from @Titomic_Limited #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Mick Shaddock answers stating TMJ implants are highly specialised to the patient and require full customisation.

Dr Katrina Skellern states it is up to the surgeon's discretion to see what would benefit the patient on a case-by-case scenario. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Question from the audience. "How can we determine the advantage of 'full customisation' compared to custom devices from a template?" #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Dr Katrina Skellern from the University of Technology Sydney investigates the health economic factors that affect all stakeholders in Australia's 3D printed medical device industry. #3dpmd

[RMIT Global Business Innovation Conversations @RMITGBIC]

George Faithfull of Stryker South Pacific talks about the challenges of regulating 3D Printed medical devices. "The TGA are looking to regulate the template of the medical device which is then customised to a certain patient under manufactuing quality control standards. " #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Mick Shaddock from OMX Solutions says joint registries are looking to capture clinical data on their custom TMJ implants. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Dr Stan Goldstein, representing @BupaAustralia, states randomised controlled trials are not the only type of clinical evidence considered by health insurers. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Dr Jasamine Coles-Black of @3dmedLab emphasises the way we collect clinical evidence needs to be adaptable. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Dominic Parsonson from @Titomic_Limited highlights the value added by utilising 3D printing technologies and emphasises the need for collaboration. #3dpmd

[RMIT Global Business Innovation Conversations @RMITGBIC]

George Faithfull from Stryker represents Large Manufacturers on the panel. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Dr Jasamine Coles-Black, co-founder of @3dmedLab represents Surgeons on the panel. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Stan Goldstein from @BupaAustralia represents Health Insurers on the panel. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Dominic Parsonson from @Titomic_Limited represents 3D printer manufacturers on the panel. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Dr Katrina Skellern from the University of Technology Sydney represents researchers on the panel. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Mick Shaddock from OMX solutions represents medical device manufacturing SMEs on the panel. #3DPMD

[RMIT Global Business Innovation Conversations @RMITGBIC]

Collaboration between different stakeholder categories is key for progress in Australia's medical device industry. #3dpmd